0001595585-19-000250.txt : 20191107
0001595585-19-000250.hdr.sgml : 20191107
20191107192406
ACCESSION NUMBER: 0001595585-19-000250
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191105
FILED AS OF DATE: 20191107
DATE AS OF CHANGE: 20191107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alpern Robert J
CENTRAL INDEX KEY: 0001448074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38558
FILM NUMBER: 191201771
MAIL ADDRESS:
STREET 1: YALE SCHOOL OF MEDICINE
STREET 2: 333 CEDAR STREET, C203 SHM
CITY: NEW HAVEN
STATE: CT
ZIP: 06520
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tricida, Inc.
CENTRAL INDEX KEY: 0001595585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463372526
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7000 SHORELINE COURT, SUITE 201
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-429-7800
MAIL ADDRESS:
STREET 1: 7000 SHORELINE COURT, SUITE 201
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
wf-form4_157317263109524.xml
FORM 4
X0306
4
2019-11-05
0
0001595585
Tricida, Inc.
TCDA
0001448074
Alpern Robert J
7000 SHORELINE COURT
SUITE 201
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2019-11-05
4
S
0
1605
39.89
D
146168
D
Common Stock
2019-11-06
4
S
0
227
39.75
D
145941
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $40.27, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
/s/ Edward J. Hejlek, attorney-in-fact
2019-11-07